Screener
Zevra Therapeutics, Inc. ZVRA Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Zevra Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
FAQ
- What is Zevra Therapeutics, Inc.'s price / sales?
- Zevra Therapeutics, Inc. (ZVRA) reported price / sales of 6.2× in Q2 2026.
- How has Zevra Therapeutics, Inc.'s price / sales changed year-over-year?
- Zevra Therapeutics, Inc.'s price / sales decreased by 22.8% year-over-year, from 8.1× to 6.2×.
- What is the long-term trend for Zevra Therapeutics, Inc.'s price / sales?
- Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s price / sales has grown at a 4.9% compound annual growth rate (CAGR), from 3.7× to 4.7×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Zevra Therapeutics, Inc.'s price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude